Using human organ-on-a-chip models to test and develop therapeutics for liver diseases and infections
A new era of blockbuster drugs is upon us. These new drugs will be used to treat serious infections and diseases of the liver. The race is on for companies to develop, test and get to market new drugs and combination therapies as quickly as possible.
Our mission is to use our proven and proprietary liver-on-a-chip platform LiverChip®, through partnerships with leading pharmaceutical companies to significantly accelerate testing of these new drugs and combinations, getting them to market in shorter time frames.
In so doing, we will help improve the quality of life for millions of people around the world.
A brief introduction to the technology can be found on the Bloomberg website here.